Internal Medicine, Hematology & Oncology · Brooklyn, NY
NPI
1811928773
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
5
Medicare group memberships
Hospitals
1
Hospital affiliations
5202 Avenue N
Brooklyn, NY, 11234
Phone (718) 928-7746
Groups this clinician bills Medicare through
Medicare paid, 2024
$67K
1,921 services
Medicare patients, 2024
114
Average age 74
Drug cost, 2024
$7.2M
2,469 prescriptions
Company payments, 2025
$566
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gardith Joseph was code 36415 (venipuncture blood collection), 365 times for 111 patients. In total Gardith Joseph billed 1,921 services in 42 codes, and Medicare paid $67K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-04-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 365 | 111 | $8.60 | $3,140 |
| 99214 Office E&M - Established | Office | 331 | 108 | $104.46 | $35K |
| 96372 Injection Administration | Office | 59 | 14 | $12.37 | $730 |
| 99211 Office E&M - Established | Office | 29 | 16 | $21.43 | $622 |
| 99213 Office E&M - Established | Office | 18 | 15 | $76.61 | $1,379 |
| 99204 Office E&M - New | Office | 13 | 13 | $128.70 | $1,673 |
By year: 2022 $60K for 1,779 services; 2023 $65K for 2,722 services; 2024 $67K for 1,921 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 365 | 111 | $8.60 | $3,140 |
Medicare prescription drug claims, 2024
In 2024, the drug Gardith Joseph prescribed most often to Medicare patients was Diphenhydramine Hcl, with 158 prescriptions and refills. In total Gardith Joseph wrote 2,469 Medicare prescriptions that cost $7.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Diphenhydramine Hcl Generic | 158 | 162 | 27 | $352 |
| Ondansetron Hcl Ondansetron Hcl/Pf | 137 | 140 | 25 | $406 |
| Anastrozole Generic | 120 | 306 | 31 | $1,579 |
| Folic Acid Generic | 103 | 220 | 36 | $177 |
| Famotidine Famotidine/Pf | 94 | 96 | 17 | $88.21 |
| Exemestane Generic | 93 | 245 | 28 | $11K |
| Dexamethasone Sodium Phosphate Dexamethasone Sodium Phosp/Pf | 82 | 86 | 17 | $593 |
| Xgeva Denosumab | 68 | 80 | 14 | $208K |
| Darzalex Daratumumab | 66 | 66 | Under 11 | $610K |
| Gabapentin Generic | 64 | 74 | 22 | $348 |
| Xtandi Enzalutamide | 62 | 72 | 11 | $1.0M |
| Dexamethasone Generic | 51 | 63 | Under 11 | $256 |
| Dexamethasone Sodium Phosphate Generic | 49 | 50 | 19 | $145 |
| Jakafi Ruxolitinib Phosphate | 49 | 49 | Under 11 | $844K |
| Letrozole Generic | 47 | 127 | 14 | $850 |
Brand drugs: 740 claims; generic drugs: 1,729 claims; opioid claims: 35.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gardith Joseph $566 ($566 in general payments such as food, travel and fees) from 13 companies. The largest payer was Incyte Corporation with $124.
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation INCY | 2 | $124 |
| Gilead Sciences, Inc. GILD | 1 | $119 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $40 |
| Genzyme Corporation SNY | 1 | $38.46 |
| PharmaEssentia USA Corporation 6446.TW | 1 | $32.22 |
| Stemline Therapeutics Inc. | 1 | $30.79 |
| Celgene Corporation BMY | 1 | $30.6 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $29.86 |
| Daiichi Sankyo Inc. 4568.T | 1 | $28.59 |
| GlaxoSmithKline, LLC. GSK | 1 | $27.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.